ACIP recommends booster dose for 12-17 year olds
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today recommended a single booster dose of the Pfizer COVID-19 vaccine for 12-17 year olds at least five months after receiving a second dose. The CDC director will now consider whether to endorse the ACIP recommendation.
The Food and Drug Administration on Jan. 3 authorized a single booster dose of the Pfizer COVID-19 vaccine for 12-15 year olds, in addition to the previously authorized 16 and 17 year olds.
Related News Articles
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…